CLASS III Device recall · Reported 1 Mar 2017 · FDA Enforcement Report

Daavlin Aquex (DAAV1000) recalled by Hidrex

Hidrex is recalling Daavlin Aquex (DAAV1000), distributed nationwide in the US. The recall was initiated on 30 Jan 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesSN# 16-3.8001 to 16-3.8250
Quantity recalled250 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1238-2017
FDA event ID
76362
Recalling firm
Hidrex, Heiligenhaus, N/A
Classification
Class III
Status
Terminated
Recall initiated
30 Jan 2017
FDA classified
22 Feb 2017
Reported
1 Mar 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Jan 2017Recall initiated by company
22 Feb 2017Classified by FDA+23 days
1 Mar 2017Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The device was reclassified from a class III device to a class II device and there are new documentation requirements.

Product as listed by the FDA

Daavlin Aquex (DAAV1000)

Where it was distributed

Nationwide throughout the US

Nationwide

Questions about this recall

Is Daavlin Aquex (DAAV1000) recalled?

Yes. Hidrex recalled Daavlin Aquex (DAAV1000) on 30 Jan 2017. The recall is Class III and its status is Terminated. Recall number Z-1238-2017.

Why was it recalled?

The device was reclassified from a class III device to a class II device and there are new documentation requirements.

Which lots are affected?

SN# 16-3.8001 to 16-3.8250

Where was it sold?

Nationwide throughout the US

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hidrex

All 3
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIIUSA DP450 recalled by HidrexHidrexOtherNationwide
DeviceCLASS IIIUSA DVP1000 recalled by HidrexHidrexOtherNationwide

Other Other Medical Devices recalls

All 13,771